Anju Mathew

Anju Mathew is the CEO and Co-Founder of OncoLens, a healthcare technology company focused on improving cancer care. Here are some key details about her background and accomplishments:

Professional Experience

• Co-founded OncoLens in 2017 with the goal of creating a platform to enable better multidisciplinary cancer care planning and treatment.12

• Prior to OncoLens, she was the head of technology innovation and partnerships at McKesson Medical Surgical.1

• Co-founded LumaMed, a medical device company focused on cancer imaging.13

• Has held strategy and technology roles at companies like Thomson Reuters, A.T. Kearney, IBM, and i2 Technologies.3

Education and Achievements

• MBA from Northwestern University's Kellogg School of Management3

• Bachelor's degree in Industrial Engineering from the Indian Institute of Technology3

• Named one of Northwestern University's Top 100 Alumni in Technology1

• Has raised over $8 million in funding as an entrepreneur3

• Won accolades like Women 2.0 2009 and the TAG top innovator's award3

Motivation for Founding OncoLens

Mathew was inspired to create OncoLens after her father was diagnosed with leukemia. While helping him navigate different treatment recommendations from multiple physicians, she saw the need for a more streamlined, collaborative approach to cancer care.1

OncoLens Impact

• The OncoLens platform is used by over 200 cancer centers in the U.S. and internationally.1

• It provides AI-driven clinical decision support tools and enables multidisciplinary collaboration among cancer care specialists.1

• The company aims to partner with 25% of U.S. cancer centers within the next three years.1

Anju Mathew is a serial entrepreneur and technology executive who has leveraged her diverse background in engineering, business, and healthcare to create innovative solutions in cancer care.